Dr. Reddy's Laboratories Limited (DRREDDY.BO)
INR 1108.55
(1.83%)
INR 1108.55
(1.83%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 55.68 Billion INR | 23.56% |
| 2022 | 45.06 Billion INR | 91.22% |
| 2021 | 23.56 Billion INR | 36.72% |
| 2020 | 17.23 Billion INR | -11.59% |
| 2019 | 19.49 Billion INR | 3.74% |
| 2018 | 18.79 Billion INR | 91.67% |
| 2017 | 9.8 Billion INR | -18.55% |
| 2016 | 12.03 Billion INR | -39.84% |
| 2015 | 20.01 Billion INR | -9.77% |
| 2014 | 22.17 Billion INR | 3.1% |
| 2013 | 21.51 Billion INR | 28.22% |
| 2012 | 16.77 Billion INR | 17.63% |
| 2011 | 14.26 Billion INR | 29.18% |
| 2010 | 11.04 Billion INR | 933.71% |
| 2009 | 1.06 Billion INR | 120.67% |
| 2008 | -5.16 Billion INR | -210.47% |
| 2007 | 4.67 Billion INR | -49.96% |
| 2006 | 9.34 Billion INR | 472.48% |
| 2005 | 1.63 Billion INR | 672.98% |
| 2004 | 211.26 Million INR | -91.48% |
| 2003 | 2.47 Billion INR | -29.6% |
| 2002 | 3.52 Billion INR | -28.35% |
| 2001 | 4.91 Billion INR | 564.92% |
| 2000 | 739.27 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 12.55 Billion INR | -9.82% |
| 2024 Q1 | 13.92 Billion INR | 6.5% |
| 2023 Q4 | 13.07 Billion INR | -5.21% |
| 2023 Q2 | 14.8 Billion INR | 5.53% |
| 2023 Q3 | 13.78 Billion INR | -6.83% |
| 2023 Q1 | 14.02 Billion INR | 46.22% |
| 2023 FY | 55.68 Billion INR | 23.56% |
| 2022 Q3 | 12.47 Billion INR | 12.07% |
| 2022 Q4 | 9.59 Billion INR | -23.09% |
| 2022 FY | 45.06 Billion INR | 91.22% |
| 2022 Q2 | 11.12 Billion INR | -6.3% |
| 2022 Q1 | 11.87 Billion INR | 1257.26% |
| 2021 Q1 | 5.7 Billion INR | 3.13% |
| 2021 Q3 | 7.06 Billion INR | -28.78% |
| 2021 Q2 | 9.92 Billion INR | 73.79% |
| 2021 FY | 23.56 Billion INR | 36.72% |
| 2021 Q4 | 875 Million INR | -87.62% |
| 2020 Q2 | 7.62 Billion INR | 31.59% |
| 2020 Q4 | 5.53 Billion INR | 2695.45% |
| 2020 Q3 | 198 Million INR | -97.4% |
| 2020 FY | 17.23 Billion INR | -11.59% |
| 2020 Q1 | 5.79 Billion INR | -24.2% |
| 2019 Q2 | 10.92 Billion INR | 64.83% |
| 2019 Q4 | 7.64 Billion INR | 234.14% |
| 2019 Q3 | -5.69 Billion INR | -152.15% |
| 2019 Q1 | 6.62 Billion INR | 52.58% |
| 2019 FY | 19.49 Billion INR | 3.74% |
| 2018 FY | 18.79 Billion INR | 91.67% |
| 2018 Q4 | 4.34 Billion INR | -10.47% |
| 2018 Q1 | 4.56 Billion INR | 50.93% |
| 2018 Q2 | 5.03 Billion INR | 10.46% |
| 2018 Q3 | 4.85 Billion INR | -3.69% |
| 2017 Q4 | 3.02 Billion INR | -9.63% |
| 2017 Q2 | 2.84 Billion INR | 382.06% |
| 2017 Q1 | 591 Million INR | -81.09% |
| 2017 FY | 9.8 Billion INR | -18.55% |
| 2017 Q3 | 3.34 Billion INR | 17.37% |
| 2016 FY | 12.03 Billion INR | -39.84% |
| 2016 Q1 | 1.26 Billion INR | 69.3% |
| 2016 Q2 | 2.95 Billion INR | 133.57% |
| 2016 Q3 | 4.7 Billion INR | 59.36% |
| 2016 Q4 | 3.12 Billion INR | -33.52% |
| 2015 Q1 | 6.25 Billion INR | 20.58% |
| 2015 Q2 | 7.21 Billion INR | 15.36% |
| 2015 Q3 | 5.79 Billion INR | -19.76% |
| 2015 Q4 | 746 Million INR | -87.12% |
| 2015 FY | 20.01 Billion INR | -9.77% |
| 2014 Q2 | 5.74 Billion INR | 4.31% |
| 2014 Q3 | 5.74 Billion INR | 0.07% |
| 2014 FY | 22.17 Billion INR | 3.1% |
| 2014 Q4 | 5.18 Billion INR | -9.68% |
| 2014 Q1 | 5.5 Billion INR | 14.29% |
| 2013 Q3 | 6.18 Billion INR | -10.41% |
| 2013 Q4 | 4.81 Billion INR | -22.13% |
| 2013 FY | 21.51 Billion INR | 28.22% |
| 2013 Q1 | 3.61 Billion INR | -36.77% |
| 2013 Q2 | 6.9 Billion INR | 91.25% |
| 2012 Q3 | 3.78 Billion INR | -7.17% |
| 2012 Q4 | 5.7 Billion INR | 50.95% |
| 2012 Q1 | 3.36 Billion INR | -1.96% |
| 2012 FY | 16.77 Billion INR | 17.63% |
| 2012 Q2 | 4.07 Billion INR | 21.25% |
| 2011 Q4 | 3.42 Billion INR | -33.21% |
| 2011 FY | 14.26 Billion INR | 29.18% |
| 2011 Q2 | 3.07 Billion INR | 17.17% |
| 2011 Q1 | 2.62 Billion INR | -21.46% |
| 2011 Q3 | 5.13 Billion INR | 66.7% |
| 2010 Q3 | 2.73 Billion INR | -4.74% |
| 2010 Q4 | 3.34 Billion INR | 22.44% |
| 2010 FY | 11.04 Billion INR | 933.71% |
| 2010 Q2 | 2.86 Billion INR | 36.83% |
| 2010 Q1 | 2.09 Billion INR | 25.89% |
| 2009 Q1 | 2.44 Billion INR | 125.01% |
| 2009 FY | 1.06 Billion INR | 120.67% |
| 2009 Q4 | 1.66 Billion INR | 131.91% |
| 2009 Q3 | -5.21 Billion INR | -340.08% |
| 2009 Q2 | 2.17 Billion INR | -11.12% |
| 2008 FY | -5.16 Billion INR | -210.47% |
| 2008 Q3 | 2.44 Billion INR | 132.27% |
| 2008 Q2 | 1.05 Billion INR | -21.8% |
| 2008 Q4 | -9.77 Billion INR | -499.88% |
| 2008 Q1 | 1.34 Billion INR | 31.36% |
| 2007 Q2 | 2.24 Billion INR | 22.73% |
| 2007 Q4 | 1.02 Billion INR | 220.92% |
| 2007 FY | 4.67 Billion INR | -49.96% |
| 2007 Q1 | 1.82 Billion INR | -43.88% |
| 2007 Q3 | -847.38 Million INR | -137.76% |
| 2006 Q3 | 1.88 Billion INR | -32.42% |
| 2006 Q4 | 3.25 Billion INR | 72.92% |
| 2006 Q2 | 2.78 Billion INR | 99.15% |
| 2006 Q1 | 1.4 Billion INR | 704.87% |
| 2006 FY | 9.34 Billion INR | 472.48% |
| 2005 FY | 1.63 Billion INR | 672.98% |
| 2005 Q1 | 347.3 Million INR | 175.16% |
| 2005 Q4 | -231.46 Million INR | -136.85% |
| 2005 Q3 | 628.12 Million INR | -29.12% |
| 2005 Q2 | 886.2 Million INR | 155.17% |
| 2004 Q3 | 36.91 Million INR | -92.86% |
| 2004 Q1 | 173.37 Million INR | 3.53% |
| 2004 FY | 211.26 Million INR | -91.48% |
| 2004 Q4 | -462.08 Million INR | -1351.81% |
| 2004 Q2 | 517.01 Million INR | 198.2% |
| 2003 FY | 2.47 Billion INR | -29.6% |
| 2003 Q3 | 591.55 Million INR | -36.46% |
| 2003 Q2 | 931.02 Million INR | 17.07% |
| 2003 Q1 | 795.25 Million INR | 19.3% |
| 2003 Q4 | 167.46 Million INR | -71.69% |
| 2002 Q3 | 694.05 Million INR | -27.19% |
| 2002 Q2 | 953.23 Million INR | -21.4% |
| 2002 Q1 | 1.21 Billion INR | 16.14% |
| 2002 FY | 3.52 Billion INR | -28.35% |
| 2002 Q4 | 666.59 Million INR | -3.96% |
| 2001 Q3 | 1.3 Billion INR | -38.31% |
| 2001 FY | 4.91 Billion INR | 564.92% |
| 2001 Q1 | 440.2 Million INR | 0.0% |
| 2001 Q4 | 1.04 Billion INR | -20.26% |
| 2001 Q2 | 2.12 Billion INR | 382.24% |
| 2000 FY | 739.27 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -804.225% |
| Aurobindo Pharma Limited | 31.72 Billion INR | -75.495% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -1082.532% |
| Granules India Limited | 4.05 Billion INR | -1273.862% |
| Indoco Remedies Limited | 984.6 Million INR | -5555.489% |
| Achyut Healthcare Limited | 5.73 Million INR | -971358.479% |
| Ajanta Pharma Limited | 8.16 Billion INR | -582.26% |
| Alkem Laboratories Limited | 17.95 Billion INR | -210.084% |
| Alpa Laboratories Limited | 167.76 Million INR | -33091.667% |
| Brooks Laboratories Limited | -195.91 Million INR | 28521.95% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -3347.712% |
| Bajaj HealthCare Limited | -837.93 Million INR | 6745.416% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -7279.851% |
| Eris Lifesciences Limited | 3.91 Billion INR | -1320.572% |
| FDC Limited | 3.05 Billion INR | -1724.369% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 470.814% |
| Gufic Biosciences Limited | 861.35 Million INR | -6364.691% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -1222.781% |
| Ipca Laboratories Limited | 5.47 Billion INR | -917.338% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -24689.209% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 28325.3% |
| Lasa Supergenerics Limited | -217.3 Million INR | 25724.695% |
| Laurus Labs Limited | 1.6 Billion INR | -3368.328% |
| Lupin Limited | 19.14 Billion INR | -190.857% |
| Mankind Pharma Limited | 19.12 Billion INR | -191.098% |
| Medicamen Biotech Limited | 109.31 Million INR | -50841.359% |
| Medico Remedies Limited | 82.9 Million INR | -67062.793% |
| Megasoft Limited | -127.46 Million INR | 43785.375% |
| NATCO Pharma Limited | 13.88 Billion INR | -301.095% |
| Piramal Pharma Limited | 178.2 Million INR | -31148.036% |
| RPG Life Sciences Limited | 876.6 Million INR | -6252.27% |
| Sigachi Industries Limited | 571.8 Million INR | -9638.336% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 41.853% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -1754.399% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -21897.14% |
| Unichem Laboratories Limited | -704.74 Million INR | 8001.32% |
| Wanbury Limited | 559.56 Million INR | -9851.337% |
| Windlas Biotech Limited | 581.87 Million INR | -9469.835% |
| ZIM Laboratories Limited | 172.46 Million INR | -32187.318% |
| Zydus Lifesciences Limited | 38.59 Billion INR | -44.278% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 1538.068% |
| Divi's Laboratories Limited | 16 Billion INR | -248.025% |
| Hester Biosciences Limited | 188.89 Million INR | -29379.591% |
| Procter & Gamble Health Limited | 2 Billion INR | -2670.624% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -12281.761% |
| Bal Pharma Limited | 73.92 Million INR | -75228.048% |
| Strides Pharma Science Limited | -706.14 Million INR | 7985.688% |
| Venus Remedies Limited | 284.9 Million INR | -19444.555% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -2467.242% |
| Nectar Lifesciences Limited | 49.95 Million INR | -111379.479% |
| Shilpa Medicare Limited | 318.74 Million INR | -17369.929% |
| Aarti Drugs Limited | 1.71 Billion INR | -3148.43% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -4042.23% |
| Suven Life Sciences Limited | -1.05 Billion INR | 5399.387% |
| Ind-Swift Limited | 142.31 Million INR | -39027.838% |
| Valiant Laboratories Limited | 3.19 Million INR | -1742202.879% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -907.622% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 1081.406% |
| Themis Medicare Limited | 435.23 Million INR | -12693.92% |
| Hikal Limited | 696.02 Million INR | -7900.345% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | -236.179% |
| Sequent Scientific Limited | -358.69 Million INR | 15624.269% |
| Novartis India Limited | 851.9 Million INR | -6436.448% |
| Wockhardt Limited | -4.63 Billion INR | 1302.678% |
| Jubilant Pharmova Limited | 771 Million INR | -7122.309% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -785066.385% |
| Neuland Laboratories Limited | 3 Billion INR | -1755.645% |
| Morepen Laboratories Limited | 961.59 Million INR | -5690.771% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -38036.069% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 61482.1% |